openPR Logo
Press release

Pharma Giants Collaboration Accelerates Access to Rare Disease Treatment – Hear more at Orphan Drugs & Rare Diseases 2018

09-19-2018 01:07 PM CET | Health & Medicine

Press release from: SMi Group

Orphan Drugs & Rare Diseases 2018

Orphan Drugs & Rare Diseases 2018

With only 4 weeks to go until SMi's 8th annual conference on Orphan Drugs & Rare Diseases (http://www.orphandrugs.co.uk/openpr), places are becoming increasingly limited and potential attendees are urged to book soon to take advantage of the exclusive opportunity of meeting and networking with a host of internationally renowned organisations to learn about the recent advances made in rare disease treatments.

Recently in rare disease industry news, seven pharmaceutical companies have announced they’re joining forces to sponsor Project Hercules, an initiative which aims to simplify the way evidence is generated for Health Technology Assessments (HTAs).

Duchenne UK, who are leading the project, and its partners aspire to create more certainty over the value of Duchenne therapies, improving their chances of becoming endorsed by HTAs.

Treatment access is delayed as assessment bodies don’t have enough evidence to make a decision. Hercules will help partners pool together valuable evidence, as well as produce evidence for similar submissions, and cut the time it takes for new treatments to get on the market.* While the new initiative focuses on DMD, it helps pave the way for similar approaches in other rare diseases.

Participants can hear more about how collaboration between regulatory agencies, pharmaceutical companies, non-profits and drug developers can accelerate HTA approval and in turn provide rare disease patients with access to life-changing therapies, at this year's Orphan Drugs and Rare Diseases conference.

The two-day event will also be hosting a pre-conference interactive workshop on 16th October, with Josie Godfrey, director at JG Zebra Consulting, sharing her experience and expertise in “Working Together for HTA in Rare Diseases - A step too far or the way forward?”.

Agenda for Workshop:

14:00 - Registration and coffee
14:30 - Workshop leader’s opening remarks and introduction
14:40 - Exploring the benefits and barriers of collaboration for HTA
- Case study: The Hercules experience in Duchenne Muscular Dystrophy (DMD)
15:25 - Afternoon tea
15:55 - Exploring opportunities for collaboration
- Breakout groups: Identifying existing and potential opportunities for collaboration in your priority areas
16:15 - Planning for success
- Discussion
17:00 - Closing remarks and end of workshop

The workshop will benefit attendees by providing an understanding of the benefits and barriers to collaboration for HTA and market access, exploring the opportunities for collaboration in priority disease areas, and planning how to maximise successful collaboration.

This year’s agenda for the conference and workshop are available to view on the website, where the latest brochure, speaker-line up and other exclusive content is also available to download. Register your place for the conference and accompanying workshop taking place on the 16th October at:

http://www.orphandrugs.co.uk/openpr

musculardystrophynews.com

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

SMi Group
1 Westminster Bridge Rd, South Bank, London SE1 7XW
Maria Mandic
mmandic@smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharma Giants Collaboration Accelerates Access to Rare Disease Treatment – Hear more at Orphan Drugs & Rare Diseases 2018 here

News-ID: 1248555 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Rare

lacit Market With Industrial Analysis by Forecast 2020-2025 | China Minmetals Ra …
This report provides in-depth study on the current state of the Global Lacit Market 2020-2025. Key players in the Global Lacit Market have been identified through the secondary research and their market share has been determined through primary and secondary research. Global Lacit Market overview: It is a compound made from lanthanum acetate and citric acid. LaCit market is segmented by Type, and by Application. Players, stakeholders, and other participants in the
What's driving the Rare Earth Metals Market growth? Great Western Minerals, Indi …
GMI presents a most up-to-date research on “Rare Earth Metals Market”– Global Industry Analysis, Size, Share, By Metal (Cerium, Dysprosium, Erbium, Europium, Gadolinium, Holmium, Lanthanum, Lutetium, Neodymium, Praseodymium, Promethium, Samarium, Scandium, Terbium, Thulium, Ytterbium, Yttrium), By Application (Magnets, Colorants, Alloys, Optical Instruments, Catalysts) Growth Potential, Trends Statistics, Regional Outlook (U.S., Canada, France, Germany, UK, Russia, Italy, China, India, Japan, Australia, Thailand, Malaysia, Brazil, Mexico, GCC) and Forecast 2017 – 2024”. According
Global Erbium Oxide Market 2017 - Chenguang Rare Earth, Longyi Heavy Rare-Earth, …
The report studies Erbium Oxide in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022 The report Global Erbium Oxide Industry provides a comprehensive analysis of the Erbium Oxide market. The report features industry insights from experts. A detailed segmentation of the Global Erbium Oxide market has been included in the
Global Dysprosium Oxide Market 2017 - Longyi Heavy Rare-Earth, China Minmetals R …
The report studies Dysprosium Oxide in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022 The report Global Dysprosium Oxide Industry 2017 is a professional, in-depth study that includes insights extracted from complex information, which clients can use for their business advantage. A large volume of precise, reliable market data has
Global Europium Oxide Market 2017 - Longyi Heavy Rare-Earth, China Minmetals Rar …
The report studies Europium Oxide in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022 The research report titled Europium Oxide has adopted an analytical approach to evaluate the dynamics of the Europium Oxide market. It provides a detailed analysis comprising an in-depth research on the Europium Oxide market growth drivers,
Global Rare Earth Metals Market 2017 - Beifang Rare Earth, Xiamen Tungsten, Sunl …
Rare Earth Metals Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. Scope of the Report: This report focuses on the Rare Earth Metals in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.